James F. Howard
机构:University of North Carolina at Chapel Hill, University of North Carolina Health Care · ORCID:0000-0002-7136-8617
发表论文 384 篇 · 总被引 13765 次 · h-index 57
代表论文
- BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial (2026 · Nature Medicine · 被引 26)
- BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial (2026 · Nature Medicine · 被引 17)
- Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis (2025 · Annals of Clinical and Translational Neurology · 被引 16)
- Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial (2026 · The Lancet · 被引 2)
- Neurobehavioral Profiles in Young Steroid-Naive Boys With Duchenne Muscular Dystrophy (2026 · Neurology · 被引 1)
- Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis (2026 · JAMA Neurology · 被引 1)